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Abstract
Urban health is potentially affected by particle emissions. The potential toxicity of nanoparticles is heavily debated
and there is an enormous global increase in research activity in this field. In this respect, it is commonly accepted
that nanoparticles may also be generated in processes occurring while driving vehicles. So far, a variety of studies
addressed traffic-related particulate matter emissions, but only few studies focused on potential nanoparticles.
Therefore, the present study analyzed the literature with regard to nanoparticles and cars. It can be stated that,
to date, only a limited amount of research has been conducted in this area and more studies are needed to
1) address kind and sources of nanoparticles within automobiles and to 2) analyse whether there are health effects
caused by these nanoparticles.
Introduction
Both outdoor and indoor air quality are important fea-
tures that directly influence individual and public health
both in occupational and environmental settings. Thus,
numerous studies addressed these issues in the past [1-6].
In previous years a large number of studies focused
on automobiles as sources for particulate matter. A few
review articles address this issue [7-10]. In contrast,
nanoparticle (NP) research has only touched the field
of automobile industry at the periphery. So far, it is
commonly accepted that NPs may be generated at the
vehicle brake, the vehicle exhaust and at road-tire abra-
sion processes (Figure 1).
Since detailed reviews have not been performed so far,
this article intends to summarize recently published data
on nanoparticle research in relation to automobiles. Hence,
this article deals with the kind of nanoparticles which may
arise from traffic as well as their potential sources.
Palladium nanoparticles: Solution-engineered NPs
as a model for health effect studies of automotive
particulate pollution
A recent study by Wilkinson et al. addressed the use of
solution-engineered palladium (Pd) nanoparticles as a
model for health effect studies of automotive particulate
pollution. The authors state that over 60% of platinum
group metals (PGMs) (Ru, Os, Rh, Ir, Pd, and Pt) are
used for the production of automobile catalytic conver-
ters [11,12]. These converters are constructed by depos-
ition of PGMs on a honeycomb-cordierite substrate
covered by a washcoat of cordierite and γ-Al2O3 [11].
There may be health effects due to particles which are
emitted from converters, but it is extremely difficult to
generate PGM-NPs. Therefore, the authors sought an
alternative for the production of these NPs by the use of
solution synthesis [11] with the production of disper-
sions of hydrophilic spherical Pd nanoparticles (Pd-NPs)
of uniform shape and size (10.4±2.7 nm) in one step by
Bradley's reaction (solvothermal decomposition in an
alcohol or ketone solvent). A similar approach also pro-
vided mixtures of Pd-NPs and nanoparticles of non-
redox-active metal oxides, such as Al2O3. The authors
furthermore studied particle aggregation in applied
media by DLS and NP tracking analysis.
Three years earlier, a group from Munich reported the
preparation and characterization of Pd/Al2O3 and Pd
nanoparticles as standardized test material for chemical
and biochemical studies of traffic related emissions [13].
Specifically, two series of Pd particles were prepared:
Pd NPs with 2–4 nm dispersed on aluminium oxide par-
ticles of a diameter range between 0.1 to 30 μm and
"Pd-only" NPs of 5–10 nm in diameter [13]. The Pd/
alpha-Al2O3 particles were reported to be very similar to
particles emitted from catalytic converters by mechanical
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ful e.g. for exposure studies in which the presence of alu-
minium could lead to interferences when studying
biological and biochemical effects [13]. In contrast to the
study by Leopold et al. who characterized the NPs using
transmission electron microscopy (TEM), high resolution
transmission electron microscopy (HRTEM), selective
area diffraction (SAD), laser granulometry and graphite
furnace atomic absorption spectrometry (GFAAS) for the
measurement of Pd concentrations [13], the group of
Wilkinson et al. also performed toxicological experi-
ments in order to assess putative health effects of the
produced Pd NPs and nanocomposite mixtures. For this
purpose, they used human primary bronchial epithelial
cells (PBEC) and human alveolar carcinoma cell line
(A549) as model system for NP-exposure [11]. They
reported that a cellular uptake of Pd nanoparticles was
only visible in PBEC, as determined by TEM. However,
they found pronounced and dose-dependent effects on
cellular secretion of soluble biomarkers both in PBECs
and A549 cells and a decreased responsiveness of human
epithelial cells to the pro-inflammatory cytokine TNF-α
[11]. Interestingly, when cells were incubated with higher
doses of the Pd nanoparticles, induction of apoptosis and
caspase activation were observed present in PBEC but
not in A549 cells [11]. In summary, the authors con-
cluded that this mode of Pd NP generation is applicable
to study the effects of Pd NPs. It is important to realize
that this study cannot be used for an exact toxicological
assessment for traffic-related health effects of Pd NPs
since it is too preliminary.
Gold nanoparticles: Subchronic inhalation
toxicity studies
Besides the use of gold nanoparticles (NPs) in cosmetics,
food packaging, beverages, toothpaste, and lubricants,
they may also be present in automobiles [14]. Since only
a few studies have reported data on the toxicology
of gold NPs so far, Sung et al. recently performed sub-
chronic inhalation studies of gold nanoparticles in
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animals were exposed for 6 hours/day, 5 days/week, for
90-days in a whole-body inhalation chamber. The aver-
age diameter of the gold NPs was 4–5 nm. The authors
studied mortality and observed clinical symptoms, body
weight, food consumption, and lung function on a
weekly basis. Also, necropsy and blood and bronchoal-
veolar lavage sample analysis were performed at the end
of the exposure protocol [14].
The authors reported that within the lung function
tests, tidal volume and minute volume showed a ten-
dency – but no significancy – to decrease comparing
control and dose groups during the 90-days of exposure
Figure 1 Generation of nanoparticles at different automobile stages.
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present in cellular differential counts. The microscopic
analysis showed an inflammatory infiltrate with a mixed
cell type, and increased macrophages in the high-dose
group of exposed animals [14]. The tissue distribution
analysis demonstrated a dose-dependent accumulation
of gold in the lungs and the kidneys [14]. Interestingly,
there was a gender-related difference in gold NP content
in the kidneys present. The authors conclude that the
lungs were the only organ in which dose-related changes
in both male and female rats were observed [14].
Particles released from low-metallic
automotive brakes
In April 2011, Kukutschová et al. reported a study that
focussed on wear particles released from commercially
available “low-metallic” automotive brake pads which
were subjected to brake dynamometer tests in the
experiments [15]. They determined particle size distribu-
tion in situ and collected the generated particles for fur-
ther studies. The collected fractions and the original
bulk material were analyzed using a multitude of techni-
ques and it was found that airborne wear particles with
sizes between 10 nm and 20 μm were released into the
air during the experiments. Interestingly, the numbers of
nanoparticles (< 100 nm) were by three orders of mag-
nitude larger in comparison to the number of micropar-
ticles [15].
Concerning the temperature, the authors stated that
size distribution of airborne wear particles generated
during brake dynamometer simulations representing
sub-urban driving segments varies in dependence on
temperature of the friction surface [15]. They found that
the generation of wear particles smaller than 500 nm
was negligible for cold surfaces, while the concentration
of nano-sized particles (< 100 nm) gradually increased
when the bulk temperature of the rotor approached
approximately 300 °C. They also reported that thermal
analysis of milled bulk brakes performed in oxidative
and inert atmospheres showed a heterogeneous ignition
mechanism of carbonaceous particles [15]. The ignition
temperature is approximately 300 °C, which correlates
with the rotor temperature when the maximum number
of finest particles was generated [15].
In total, the analysed friction composite was a multi-
component heterogeneous material. However, the dom-
inant elements in the finest wear particle fractions were
Fe and C. It was not easy to distinguish Cu, Sn and other
metals/oxides in diffraction measurement. Further PIXE
analysis revealed the presence of Fe, Cu, Sn, Zn and S in
all fractions [15].
Wear particle analysis was performed using Raman
microspectroscopy and showed the presence of carbon
black and graphitic particles. Also, TEM-diffraction
analysis identified the presence of maghemite (γ-Fe2O3),
magnetite (FeOFe2O3) and hematite (α-Fe2O3) in col-
lected nano fractions. All wear particle fractions con-
tained nano-sized particles down to 20 nm in diameter
in the form of agglomerates [15].
The authors concluded that wear of low-metallic fric-
tion composite produces airborne NPs. These NPs con-
tain carbon black and a variety of metallic compounds
(Figure 2). It needs to be stated that a comprehensive
evaluation of particles which contribute to air pollution
as presently performed requires a combination of several
microscopic techniques and chemical analyses to deter-
mine the real size of individual particles present in par-
ticulate matter [15].
Organometallic fuel additives and nanoparticle
emissions from gasoline passenger cars
Gidney and colleagues stated in their recent article that
the European particle measurement program (PMP) and
the new EURO 6 regulations on particle emissions from
diesel cars were intended to promote the use of diesel
particulate filters (DPFs) but excluded particles smaller
than 23 nm because of measurement difficulties in that
size range [16]. However, these regulations do not imply
that particles below 23 nm are benign and to clarify the
fate of organometallic gasoline fuel additives from a
gasoline engines, the authors studied particulate number
and size distributions in the exhaust line of a typical
European family passenger car with a 1.6 L four cylinder
spark ignition engine (multi point injection, 4 cylinder,
1.6 L displacement, catalyst volume 1.66 L, European
Stage 3 emissions standards) fuelled with standard
gasoline and gasoline containing an organometallic addi-
tives [16]. Three additives were tested: CH3C5H4Mn
(CO)3, Fe(Cp)2 and PbEt4. Two concentrations of
CH3C5H4Mn(CO)3 were used, 8.3 mg/L (Mn-8) and
18 mg/L (Mn-18) of manganese. These concentrations
represent levels that were historically permitted in the
U.S. and Canada, respectively. One concentration was
used for the FeCp2 and PbEt4 tests (Fe-8−8.4 mg/L and
Pb-30−31.3 mg/L). This was the same concentration of
metal in the fuel as the Mn-8 case [16]. They measured
particle size on the exhaust of a car operating on a chas-
sis dynamometer fuelled with standard gasoline and
gasoline containing low levels of Pb, Fe, and Mn organo-
metallic additives. Interestingly, when additives were
present in the experimental setup, there was a distinct
nucleation mode consisting primarily of sub-10 nm
nanoparticles [16]. It was found that at equal molar dos-
ing Mn and Fe gave similar NP concentrations at the
tailpipe, whereas Pb gave a considerably lower concen-
tration. In further experiments the authors used a cata-
lytic stripper in order to remove the organic component
of these particles. It was shown that they were mainly
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additives, presumably inorganic [16].
The authors stated that solid nucleation mode NPs of
similar size and concentration to those observed in the
present study from a gasoline engine with Mn and Fe
additives have also been observed from modern heavy-
duty diesel engines without after-treatment at idle, but
these solid particles are a small fraction of the primarily
volatile nucleation mode particles emitted [16]. The
authors suggested that solid nucleation mode particles
emitted by the diesel engines are likely derived from
metal compounds in the lubrication oil, although car-
bonaceous particles cannot be ruled out. They also
stated that most of these solid nanoparticles emitted by
both engine types fall below the 23 nm cutoff of the
PMP number regulation.
Conclusion
In view of the current research on nanoparticles, it
needs to be stated that the amount of published articles
on nanoparticles, which may arise from traffic, is still
largely limited. Therefore, modern scientometric tools
which are in use for the analysis of other research fields
are not applicable in this area [17-29].
As a conclusion, there is a lack of information present
regarding a) levels of nanoparticles that are emitted from
automobiles b) effects of nanoparticles with regard to
the emission levels. There are numerous approaches
present which may bring light into this field of
environmental sciences. Specifically, sources and levels
of different NPs need to be identified and analyzed.
Additionally, further toxicological research should be
performed about molecular mechanisms, i.e. with the
use of advanced techniques of biochemistry [30-33] and
molecular biology [34-38].
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